Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
BIND Therapeutics
Work at BIND Therapeutics?
Add yourself to this profile
3331
BIND Therapeutics
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Edit Profile
bindtherapeutics.com
Health Care
Technology
>
Biotechnology
B2c
Founded in
2006
Inactive
Raised
$37.9M
More info
Elsewhere
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Mobile.co
nuTonomy
HubSpot
Biogen
General Catalyst
Harvard University
Companies in the same industry
NestSense
Lysosomal Therapeutics
BioVentrix
Pfizer Inc.
Ironwood Pharma
Blueprint Medicines
Immune Design
Endocyte
Epinex Diagnostics
VisionGate Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
Venture capital (Series D)
$25,500,000
RUSNANO
Venture capital (Series C)
$12,400,000
Endeavour Vision
,
Flagship Ventures
,
Polaris Partners
, +2
Employees
Team size
50+
Locations
HQ
Cambridge
,
United States
Headquarters
Xconomy
Pfizer Might Buy Bind Therapeutics From Bankruptcy for $20M
Health
Legal
Xconomy
Bind Therapeutics Sheds Employees, Considers New Capital or Deals
Health
Funding
MIT
Raspberry Pi
ARM
Xconomy
Mobile.co
nuTonomy
HubSpot
Biogen
General Catalyst
Harvard University
BioVentrix
Pfizer Inc.
Ironwood Pharma
Blueprint Medicines
Immune Design
Endocyte
Epinex Diagnostics